MacroGenics, Inc.

BRSE:M55 Stock Report

Market Cap: CHF 216.8m

MacroGenics Management

Management criteria checks 1/4

MacroGenics' CEO is Eric Risser, appointed in Aug 2025, has a tenure of 1.08 years. total yearly compensation is $2.08M, comprised of 27% salary and 73% bonuses, including company stock and options. directly owns 0.12% of the company’s shares, worth CHF262.58K. The average tenure of the management team and the board of directors is 1.5 years and 5.6 years respectively.

Key information

Eric Risser

Chief executive officer

US$2.1m

Total compensation

CEO salary percentage27.01%
CEO tenure1.1yrs
CEO ownership0.1%
Management average tenure1.5yrs
Board average tenure5.6yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Eric Risser's remuneration changed compared to MacroGenics's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

-US$101m

Mar 31 2026n/an/a

-US$74m

Dec 31 2025US$2mUS$562k

-US$75m

Sep 30 2025n/an/a

-US$83m

Jun 30 2025n/an/a

-US$44m

Mar 31 2025n/an/a

-US$57m

Dec 31 2024n/an/a

-US$67m

Sep 30 2024n/an/a

-US$98m

Jun 30 2024n/an/a

-US$136m

Mar 31 2024n/an/a

-US$23m

Dec 31 2023n/an/a

-US$9m

Sep 30 2023n/an/a

US$50m

Jun 30 2023n/an/a

US$7m

Mar 31 2023n/an/a

-US$91m

Dec 31 2022US$2mUS$461k

-US$120m

Sep 30 2022n/an/a

-US$191m

Jun 30 2022n/an/a

-US$219m

Mar 31 2022n/an/a

-US$217m

Dec 31 2021US$2mUS$428k

-US$202m

Sep 30 2021n/an/a

-US$146m

Jun 30 2021n/an/a

-US$129m

Mar 31 2021n/an/a

-US$136m

Dec 31 2020US$1mUS$431k

-US$130m

Sep 30 2020n/an/a

-US$158m

Jun 30 2020n/an/a

-US$167m

Mar 31 2020n/an/a

-US$152m

Dec 31 2019US$2mUS$388k

-US$152m

Compensation vs Market: Eric's total compensation ($USD2.08M) is above average for companies of similar size in the Swiss market ($USD941.53K).

Compensation vs Earnings: Eric's compensation has increased whilst the company is unprofitable.

CEO

Eric Risser (53 yo)

1.1yrs
Tenure
US$2,078,854
Compensation

Mr. Eric Blasius Risser is President, Chief Executive Officer and Director at MacroGenics, Inc. since August 13, 2025. He served as Chief Operating Officer at MacroGenics, Inc. since February 22, 2022 unti...

Leadership Team

NamePositionTenureCompensationOwnership
Eric Risser
CEO, President & Director1.1yrsUS$2.08m0.12%
CHF 262.6k
James Karrels
Senior VP & CFO18.3yrsUS$1.15m0.32%
CHF 701.1k
Ezio Bonvini
Senior VP of Research & Chief Scientific Officer10yrsUS$1.22m0.29%
CHF 632.2k
Araba Lamouse-Smith
Vice President of Technical Operationsless than a yearno datano data
Jeffrey Peters
Senior VP9.3yrsno data0%
CHF 0
Steve Harig
Senior Vice President of Human Resourcesno datano datano data
Harish Krishnaswamy
Senior Vice President of Business Development & Portfolio Planning1.1yrsno datano data
Frank Perabo
Vice President & Interim Head of Clinical Development1.2yrsno datano data
Beth Smith
VP, Controller & Treasurer1.8yrsno data0.020%
CHF 43.5k
1.5yrs
Average Tenure
58.5yo
Average Age

Experienced Management: M55's management team is not considered experienced ( 1.5 years average tenure), which suggests a new team.

Board Members

NamePositionTenureCompensationOwnership
Eric Risser
CEO, President & Director1.1yrsUS$2.08m0.12%
CHF 262.6k
David Stump
Independent Director13yrsUS$95.86k0.023%
CHF 50.2k
Federica O'Brien
Independent Director5.6yrsUS$110.48k0.023%
CHF 50.2k
Edward Hurwitz
Independent Director21.9yrsUS$85.86k0.075%
CHF 162.7k
Margaret Liu
Independent Director3.7yrsUS$85.86k0.023%
CHF 50.2k
Scott Koenig
Director25yrsUS$969.84k2.3%
CHF 5.0m
William Heiden
Independent Chairman of the Board4.3yrsUS$145.03k0.18%
CHF 390.5k
Meenu Chhabra Karson
Independent Director3.7yrsUS$80.22k0.023%
CHF 50.2k
Scott Jackson
Independent Director9.7yrsUS$81.91k0.023%
CHF 50.2k
5.6yrs
Average Tenure
66yo
Average Age

Experienced Board: M55's board of directors are considered experienced (5.6 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/09/20 03:46
End of Day Share Price 2026/09/18 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

MacroGenics, Inc. is covered by 20 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Peter LawsonBarclays
Etzer DaroutBarclays
"Etzer DaroutBarclays